Top Markets
#1 Black Phoenix Black Phoenix +350.87%
#2 Islamic Coin Islamic Coin +158.26%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.42%
#5 DOVU DOVU +18.91%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.19%
#7 Pons Pons +9.08%
#8 MarsCoin MarsCoin +8.69%
#9 stake.link stake.link +8.24%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +8.18%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.

InNexus Biotechnology, Inc.

IXSBF
Classifica tra le azioni #41696
InNexus Biotechnology, Inc. is a development-stage company dedicated to... InNexus Biotechnology, Inc. is a development-stage company dedicated to advancing and commercializing monoclonal antibodies. Its efforts are underpinned by its proprietary Dynamic Cross Linking (DXL) technology. This DXL platform is designed to boost the therapeutic efficacy of conventional monoclonal antibody treatments by strengthening their binding to target antigens, amplifying their effector functions, and endowing them with novel properties. InNexus's development portfolio features several investigational therapies: DXL625: A monoclonal antibody currently in late-stage pre-clinical development, engineered for superior binding kinetics and enhanced effector functions, intended for treating B-cell non-Hodgkin's lymphoma (NHL). DXLr120: A recombinant DXL anti-CD20 antibody also being developed for B-cell NHL. DXL702: A monoclonal antibody targeting metastatic breast cancer. DXL1218: An agent designed to target the epidermal growth factor receptor (EGFR), an antigen frequently overexpressed in metastatic colorectal cancer and squamous cell carcinomas of the head and neck. The company also maintains strategic partnerships with XERIS Pharmaceuticals, Genhelix, Evogenix, Affimed, and Corixa. InNexus Biotechnology, Inc. is based in Vancouver, Canada.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2025-11-07
Capitalizzazione di mercato
$12.63K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
CA
Scambia InNexus Biotechnology, Inc. (IXSBF)

Categoria

Healthcare
Il prezzo IXSBF con la capitalizzazione del mercato della B
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.
IXSBF
$0.0001
Capitalizzazione di mercato di InNexus Biotechnology, Inc.(IXSBF)
Capitalizzazione di mercato: $12.63K
A partire dal August 2026, InNexus Biotechnology, Inc. ha una capitalizzazione di mercato pari a $12.63K. Questo rende InNexus Biotechnology, Inc. la 41696th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di InNexus Biotechnology, Inc. dal 2005 al 2026
IXSBF in paragone con la classifica dei più popolari stocks
Il prezzo per IXSBF Attivo B Capitalizzazione del mercato a B Risultati
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.
$42,633.72 $12.63K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +42,633,717,014.12%
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.
$35,031.21 $12.63K
Apple Inc. Apple Inc.
AAPL
$4.423T +35,031,212,410.79%
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.
$32,948.20 $12.63K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +32,948,201,365.76%
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.
$29,011.81 $12.63K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +29,011,806,639.53%
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.
$22,897.19 $12.63K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +22,897,194,763.39%